|4Feb 18, 7:05 PM ET

ELITE PHARMACEUTICALS INC /NV/ 4

4 · ELITE PHARMACEUTICALS INC /NV/ · Filed Feb 18, 2016

Insider Transaction Report

Form 4
Period: 2016-02-16
Hakim Nasrat A
DirectorPresident & CEO
Transactions
  • Award

    Common Stock

    2016-02-16$0.25/sh+2,854,279$699,86922,040,747 total
Holdings
  • Common Stock

    (indirect: By IRA)
    2,700,000

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT